Prior to the global emergence of SARS-CoV-2 (COVID-19), most countries and their respective governmental health ministries were lulled into a false sense of biosecurity. The health and economic impacts of COVID-19 are a stark reminder of the catastrophic risks microbial pathogens pose in our globalized society. Considering there is an 80% chance of another pandemic…
Philanthropic funding for emerging infectious disease research has steadily increased by about 10% annually between 2014-2019 in response to epidemics around the globe, such as MERS, Ebola, Zika, and Chikungunya. As the world scrambled to control the SARS-CoV-2 pandemic (COVID-19), philanthropic funding in the emerging infectious disease space spiked 290% in 2020 and fell by…